155 related articles for article (PubMed ID: 8471424)
21. Phorbol ester-mediated inhibition of growth and regulation of proto-oncogene expression in the human T cell leukemia line JURKAT.
Makover D; Cuddy M; Yum S; Bradley K; Alpers J; Sukhatme V; Reed JC
Oncogene; 1991 Mar; 6(3):455-60. PubMed ID: 2011401
[TBL] [Abstract][Full Text] [Related]
22. Amplification and overexpression of c-myc proto-oncogene correlate with the loss of glucocorticoid dependence in rodent cells transformed by human papillomavirus type 16.
Crook T; Banks L; Smith K; Crawford L
Mol Carcinog; 1989; 2(6):308-13. PubMed ID: 2482744
[TBL] [Abstract][Full Text] [Related]
23. Retinoic acid induces down-regulation of several growth factors and proto-oncogenes in a human embryonal cancer cell line.
Miller WH; Moy D; Li A; Grippo JF; Dmitrovsky E
Oncogene; 1990 Apr; 5(4):511-7. PubMed ID: 2158037
[TBL] [Abstract][Full Text] [Related]
24. Telomerase reverse transcriptase promoter regulation during myogenic differentiation of human RD rhabdomyosarcoma cells.
Ma H; Urquidi V; Wong J; Kleeman J; Goodison S
Mol Cancer Res; 2003 Aug; 1(10):739-46. PubMed ID: 12939399
[TBL] [Abstract][Full Text] [Related]
25. Up-regulation of c-myc in a transformed cell line approaching stationary phase growth in culture.
Mulder KM; Levine AE; Hinshaw XH
Cancer Res; 1989 May; 49(9):2320-6. PubMed ID: 2706619
[TBL] [Abstract][Full Text] [Related]
26. p21WAF1 expression induced by MEK/ERK pathway activation or inhibition correlates with growth arrest, myogenic differentiation and onco-phenotype reversal in rhabdomyosarcoma cells.
Ciccarelli C; Marampon F; Scoglio A; Mauro A; Giacinti C; De Cesaris P; Zani BM
Mol Cancer; 2005 Dec; 4():41. PubMed ID: 16351709
[TBL] [Abstract][Full Text] [Related]
27. Transforming growth factor beta and dexamethasone cooperatively enhance c-jun gene expression and inhibit the growth of human monocytoid leukemia cells.
Kanatani Y; Kasukabe T; Okabe-Kado J; Hayashi S; Yamamoto-Yamaguchi Y; Motoyoshi K; Nagata N; Honma Y
Cell Growth Differ; 1996 Feb; 7(2):187-96. PubMed ID: 8822202
[TBL] [Abstract][Full Text] [Related]
28. Morphological and molecular characterization of spontaneous myogenic differentiation in a human rhabdomyosarcoma cell line.
Shapiro DN; Houghton PJ; Hazelton BJ; Germain GS; Murti KG; Rahman A; Houghton JA
Cancer Res; 1990 Sep; 50(18):6002-9. PubMed ID: 2203524
[TBL] [Abstract][Full Text] [Related]
29. Differentiation primary response genes and proto-oncogenes as positive and negative regulators of terminal hematopoietic cell differentiation.
Liebermann DA; Hoffman B
Stem Cells; 1994 Jul; 12(4):352-69. PubMed ID: 7951003
[TBL] [Abstract][Full Text] [Related]
30. Regulation of cell proliferation: late down-regulation of c-myb preceding myelo-monocytic cell differentiation.
Yen A; Samuel V; Forbes M
J Cell Physiol; 1992 Oct; 153(1):147-56. PubMed ID: 1522128
[TBL] [Abstract][Full Text] [Related]
31. Inverse expression of mdr 1 and c-myc genes in a rhabdomyosarcoma cell line resistant to actinomycin d.
Prados J; Melguizo C; Fernández A; Aránega AE; Alvarez L; Aránega A
J Pathol; 1996 Sep; 180(1):85-9. PubMed ID: 8943821
[TBL] [Abstract][Full Text] [Related]
32. Synergistic effect of recombinant human leukemia inhibitory factor (LIF) and 1-beta-D-arabinofuranosylcytosine (Ara-C) on proto-oncogene expression and induction of differentiation in human U 937 cells.
Brach MA; Riedel D; Mertelsmann RH; Herrmann F
Leukemia; 1990 Sep; 4(9):646-9. PubMed ID: 2144331
[TBL] [Abstract][Full Text] [Related]
33. Antisense epidermal growth factor receptor transfection impairs the proliferative ability of human rhabdomyosarcoma cells.
De Giovanni C; Landuzzi L; Frabetti F; Nicoletti G; Griffoni C; Rossi I; Mazzotti M; Scotto L; Nanni P; Lollini PL
Cancer Res; 1996 Sep; 56(17):3898-901. PubMed ID: 8752155
[TBL] [Abstract][Full Text] [Related]
34. Heterogeneous response to differentiation induction in different clonal subpopulations of a rat rhabdomyosarcoma cell line (BA-HAN-1).
Gerharz CD; Gabbert HE; Engers R; Ramp U; Mayer H; Biesalski HK; Luley C
Cancer Res; 1989 Dec; 49(24 Pt 1):7132-40. PubMed ID: 2582454
[TBL] [Abstract][Full Text] [Related]
35. Sensitivity of nuclear c-myc levels and induction to differentiation-inducing agents in human colon tumor cell lines.
Taylor CW; Kim YS; Childress-Fields KE; Yeoman LC
Cancer Lett; 1992 Feb; 62(2):95-105. PubMed ID: 1540946
[TBL] [Abstract][Full Text] [Related]
36. Redundancy of autocrine loops in human rhabdomyosarcoma cells: induction of differentiation by suramin.
De Giovanni C; Melani C; Nanni P; Landuzzi L; Nicoletti G; Frabetti F; Griffoni C; Colombo MP; Lollini PL
Br J Cancer; 1995 Nov; 72(5):1224-9. PubMed ID: 7577472
[TBL] [Abstract][Full Text] [Related]
37. Ara-C treatment leads to differentiation and reverses the transformed phenotype in a human rhabdomyosarcoma cell line.
Crouch GD; Kalebic T; Tsokos M; Helman LJ
Exp Cell Res; 1993 Feb; 204(2):210-6. PubMed ID: 8440318
[TBL] [Abstract][Full Text] [Related]
38. Glucocorticoids induce a G1/G0 cell cycle arrest of Con8 rat mammary tumor cells that is synchronously reversed by steroid withdrawal or addition of transforming growth factor-alpha.
Goya L; Maiyar AC; Ge Y; Firestone GL
Mol Endocrinol; 1993 Sep; 7(9):1121-32. PubMed ID: 8247014
[TBL] [Abstract][Full Text] [Related]
39. Proto-oncogene expression and dissection of the myeloid growth to differentiation developmental cascade.
Liebermann DA; Hoffman-Liebermann B
Oncogene; 1989 May; 4(5):583-92. PubMed ID: 2471131
[TBL] [Abstract][Full Text] [Related]
40. Control of c-fos and c-myc proto-oncogene induction in rat thyroid cells in culture.
Isozaki O; Kohn LD
Mol Endocrinol; 1987 Nov; 1(11):839-48. PubMed ID: 2856403
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
